Cellectis (CLLS) Net Shares Issued and Repurchased (2013 - 2018)
Powered by 
Analysis
Cellectis (CLLS) Net Shares Issued and Repurchased (2013 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 297,000.00 |
| Sep 30, 2018 | 297,000.00 |
| Jun 30, 2018 | -291,000.00 |
| Mar 31, 2018 | -76,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | 114,000.00 |
| Jun 30, 2017 | 117,000.00 |
| Mar 31, 2017 | 158,000.00 |
| Dec 31, 2016 | -133,885.80 |
| Sep 30, 2016 | -211,000.00 |
| Jun 30, 2016 | -63,273.00 |
| Mar 31, 2016 | -6,618.07 |
| Dec 31, 2015 | 73,439.86 |
| Sep 30, 2015 | -98,993.36 |
| Jun 30, 2015 | 68,518.76 |
| Mar 31, 2015 | 92,646.26 |
| Dec 31, 2014 | 201,223.19 |
| Dec 31, 2013 | -326,661.50 |